21 research outputs found
The Modern Mastectomy
Get PDFObjectives:
1. Understand the development of the modern mastectomy.
2. Appreciate the current utility of the modern mastectomy.
3. Consider the future of the modern mastectomy.
Presentation: 29 minute
The Modern Mastectomy
No full textObjectives Perspective on the historic importance of the mastectomy Pressures driving the resurgence of the mastectomy Principles of the modern mastectom
Tumor hormone receptor status and recurrences in premenopausal patients with node-negative breast carcinoma
Full text linkThe Implementation and Efficacy of a Breast Cancer Wellness Group at Thomas Jefferson University Hospital
Get PDFAbstract
Introduction: Breast cancer is not only a physical disease but something that affects our patients’ mental, spiritual, emotional and social wellbeing. There has been literature that demonstrates the positive benefits of exercise, social support, and nonmedical adjuncts for breast cancer patients. There is currently a lack of wellness support within the Jefferson breast cancer community.
Methods: A wellness survey will be distributed throughout the breast surgery and breast oncology clinics to assess the current level of wellness and interest in a breast cancer wellness group at TJUH. This survey will be used both before and after implementation of a wellness group to assess its efficacy within our community.
Results: Pending
Discussion: We believe a breast cancer wellness group will address a major need of support within our Jefferson breast cancer community. This project will not only allow us to meet this need but to assess the basic social, mental, spiritual, and emotional needs of our patients in order to improve our overall patient care.https://jdc.jefferson.edu/patientsafetyposters/1123/thumbnail.jp
Can routine cavity shave margins (CSM) improve local control in breast cancer? Initial results of the SHAVE trial, a prospective randomized controlled trial of routine CSM vs. standard partial mastectomy (SPM).
No full textA retrospective review of clinical and pathologic aspects of inflammatory breast cancer: Clues for risk-adapted monitoring and therapy.
No full text
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
No full textPURPOSE: Discordance between HER2 expression in tumor tissue (tHER2) and HER2 status on circulating tumor cells (cHER2) has been reported. It remains largely underexplored whether patients with tHER2
METHODS: cHER2 status was determined in 105 advanced-stage patients with tHER2
RESULTS: Compared to the patients with low-risk cHER2 (cHER2
CONCLUSION: In advanced-stage breast cancer patients with tHER
African American Women Who Receive Primary Anthracycline- and Taxane-Based Chemotherapy for Triple-Negative Breast Cancer Suffer Worse Outcomes Compared With White Women
No full text
